RAYNE ROUCE to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications RAYNE ROUCE has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
1.388
-
Targeted cellular therapy for treatment of relapsed or refractory leukemia. Best Pract Res Clin Haematol. 2023 09; 36(3):101481.
Score: 0.474
-
More than Memory: Potential of Adaptive Natural Killer Cells. Biol Blood Marrow Transplant. 2015 Sep; 21(9):1534-6.
Score: 0.276
-
Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant. Curr Opin Hematol. 2014 Nov; 21(6):476-81.
Score: 0.262
-
Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplant Cell Ther. 2024 Dec; 30(12):1124-1138.
Score: 0.130
-
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica. 2023 03 01; 108(3):747-760.
Score: 0.117
-
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation. Blood. 2018 11 29; 132(22):2351-2361.
Score: 0.086
-
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells. J Transl Med. 2019 07 24; 17(1):240.
Score: 0.023
-
In?Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas. Mol Ther. 2018 12 05; 26(12):2727-2737.
Score: 0.021